We are live on ! Find out more
BPCE

Bank Pictet & Cie (Europe) Portfolio holdings

AUM $5.12B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+11.01%
1 Year Est. Return
+27.39%
3 Year Est. Return
+99.4%
5 Year Est. Return
+123.97%
10 Year Est. Return
+508.14%
AUM
$2.93B
AUM Growth
+$235M
Cap. Flow
-$15.4M
Cap. Flow %
-0.53%
Top 10 Hldgs %
44.67%
Holding
186
New
18
Increased
73
Reduced
52
Closed
6

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$15.6M
2
APD icon
Air Products & Chemicals
APD
+$15.1M
3
EOG icon
EOG Resources
EOG
+$14.4M
4
AMZN icon
Amazon
AMZN
+$9.05M
5
MA icon
Mastercard
MA
+$7.91M

Sector Composition

Rank Sector Weight
1 Healthcare 24.57%
2 Technology 21.52%
3 Consumer Discretionary 14.33%
4 Communication Services 13.93%
5 Financials 8.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TT icon
126
Trane Technologies
TT
$105B
$609K 0.02%
3,013
+459
+18% +$86.4K
TXG icon
127
10x Genomics
TXG
$7.52B
$567K 0.02%
3,806
+467
+14% +$71.5K
IEUR icon
128
iShares Core MSCI Europe ETF
IEUR
$9.14B
$550K 0.02%
9,465
-700
-7% -$40.5K
NFLX icon
129
Netflix
NFLX
$309B
$530K 0.02%
8,800
-1,650
-16% -$105K
WDAY icon
130
Workday
WDAY
$43.3B
$508K 0.02%
1,858
+360
+24% +$100K
PACB icon
131
Pacific Biosciences
PACB
$345M
$499K 0.02%
24,393
+9,052
+59% +$218K
ARWR icon
132
Arrowhead Research
ARWR
$12.3B
$490K 0.02%
7,395
+952
+15% +$65.4K
IOVA icon
133
Iovance Biotherapeutics
IOVA
$3.05B
$477K 0.02%
24,989
+2,927
+13% +$64.4K
B
134
Barrick Mining
B
$67.9B
$455K 0.02%
+23,931
New +$454K
PODD icon
135
Insulet
PODD
$10.1B
$449K 0.02%
1,686
-418
-20% -$121K
XBI icon
136
State Street SPDR S&P Biotech ETF
XBI
$10.5B
$447K 0.02%
3,989
-91,085
-96% -$11M
ABBV icon
137
AbbVie
ABBV
$440B
$437K 0.01%
3,230
CSTL icon
138
Castle Biosciences
CSTL
$960M
$415K 0.01%
9,689
+1,065
+12% +$55.6K
AGG icon
139
iShares Core US Aggregate Bond ETF
AGG
$138B
$407K 0.01%
3,572
-380
-10% -$43.5K
VCSH icon
140
Vanguard Short-Term Corporate Bond ETF
VCSH
$45B
$393K 0.01%
4,832
TWST icon
141
Twist Bioscience
TWST
$7.85B
$361K 0.01%
4,668
+2,134
+84% +$219K
LMT icon
142
Lockheed Martin
LMT
$140B
$355K 0.01%
1,000
DVA icon
143
DaVita
DVA
$11.6B
$341K 0.01%
+3,000
New +$322K
PRGO icon
144
Perrigo
PRGO
$1.76B
$337K 0.01%
8,650
RDS.A
145
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$317K 0.01%
+7,300
New +$330K
CRSP icon
146
CRISPR Therapeutics
CRSP
$5.22B
$309K 0.01%
4,076
+532
+15% +$46.5K
APLS
147
DELISTED
Apellis Pharmaceuticals
APLS
$300K 0.01%
+6,335
New +$249K
ORCL icon
148
Oracle
ORCL
$442B
$299K 0.01%
3,433
CVX icon
149
Chevron
CVX
$386B
$297K 0.01%
2,529
-144,923
-98% -$16.5M
LQD icon
150
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.7B
$293K 0.01%
2,212
-440
-17% -$58.5K

Similar funds

Bank Pictet & Cie (Europe)'s Q4 2021 Portfolio in Review

As of Q4 2021, Bank Pictet & Cie (Europe) held 186 positions worth $2.93B, up 8.7% from $2.7B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Bank Pictet & Cie (Europe)'s Q4 2021 filing shows 18 new, 73 increased, 52 reduced and 6 closed positions. Its largest new stake was Intercontinental Exchange: 45,981 shares worth $6.29M. The largest sale was Chevron, an estimated $16.5M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Bank Pictet & Cie (Europe)'s largest Q4 2021 buy was Intercontinental Exchange: 45,981 shares worth $6.29M.
  • Bank Pictet & Cie (Europe) added most to Thermo Fisher Scientific in Q4 2021, an estimated $15.6M increase.
  • Bank Pictet & Cie (Europe)'s biggest Q4 2021 reduction was Chevron, cutting an estimated $16.5M.
  • Bank Pictet & Cie (Europe) fully exited Cooper Companies in Q4 2021, selling an estimated $2.88M.
  • Bank Pictet & Cie (Europe)'s ten largest holdings make up 45% of its $2.93B portfolio in Q4 2021.
  • Bank Pictet & Cie (Europe) opened 18 new positions and closed 6 in Q4 2021.
  • Bank Pictet & Cie (Europe)'s portfolio value rose 8.7% quarter-over-quarter to $2.93B.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q4 2021, filed 2 Feb 2022.